Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709317 | 0.89 | TGFBR1 (0.37) | MAPTMEN1XBP1MAPK1NTSR1 | |
| SCHEMBL30709566 | 0.87 | PSMB5 (0.31) | — | |
| SCHEMBL30709228 | 0.86 | NOTUM (0.36) | MAPTMEN1KMT2A | |
| SCHEMBL30709410 | 0.86 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL30561050 | 0.85 | APP (0.34) | MAPTMEN1XBP1MAPK1NTSR1 | |
| SCHEMBL30709446 | 0.84 | CYP11B1 (0.38) | MAPTMEN1 | |
| SCHEMBL22148687 | 0.84 | CYP11B1 (0.38) | MAPTMEN1 | |
| SCHEMBL30709259 | 0.83 | IRAK4 (0.34) | MAPTMAPK1SMN1; SMN2L3MBTL1HTT | |
| SCHEMBL21046107 | 0.81 | APP (0.36) | MAPTMEN1XBP1MAPK1NTSR1 | |
| SCHEMBL20771009 | 0.81 | ALDH1A3 (0.40) | MAPTMEN1MAPK1KMT2AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | CRHR1 4505/4885MAPT 275/4885MEN1 2193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.